
unlisted shares
₹380
(-115.00) (-35.38%)₹3,633 Cr
93.9
INE127G01010
-38.4
1000
₹380
| Company | NCDEX |
| Incorporation Date | April 23, 2003 |
| ISIN Number | INE127G01010 |
| PAN | AABCI9479D |
| CIN | U51909MH2003PLC140116 |
| Corporate Office | Ackruti Corporate Park, 1st Floor, LBS Road, Kanjurmarg (W.), Mumbai - 400 078 |
| Sector | Commodity Exchange |
| Depository | CDSL & NSDL |
| Face Value | 10 |
| Book Value | 93.9 |
No Data to show for this.
| PARTICULARS | FY23 | FY24 | FY25 | FY26LATEST |
|---|---|---|---|---|
| REVENUE | 104 | 96 | 88 | 90.4▲3% |
| EBITDA | -66 | -65 | -83 | -103.6▼25% |
| OPM (%) | -63.46 | -67.71 | -94.32 | -114.6▼22% |
| PBT | -58 | -33 | 279 | -64▼123% |
| PAT | -42 | -28 | 236 | -46▼119% |
| EPS (₹) | -8.29 | -5.52 | 46.57 | -5.13▼111% |
| Name | Designation | Experience | |
|---|---|---|---|
| Mr. Ashish Bahuguna | Chairman | 30+ | - |
| Mr. Arun Raste | MD & CEO | 30+ | - |
| Atul Roongta | CFO | - | - |
National Commodity and Derivatives Exchange Limited is India's leading exchange for agricultural commodity derivatives. Incorporated in April 2003 and headquartered in Mumbai, the exchange is regulated by SEBI and holds shares in dematerialised form with both CDSL and NSDL. Revenue derives primarily from transaction charges on traded volume, supported by membership fees, market data services and clearing income.
Current Position
Since December 2021, SEBI has suspended derivatives trading in seven agricultural commodities, including wheat, chana, mustard seed and soybean. These contracts previously accounted for a substantial majority of exchange volumes, and the suspension has been extended on multiple occasions. The exchange therefore operates below its historical earnings capacity, with the constraint regulatory rather than operational in nature. The profit recorded in FY25 arose outside core operations and is appropriately read as non-recurring.
Valuation Considerations
With the company loss-making at the net level, earnings-based multiples carry limited analytical value. Valuation rests principally on the balance sheet and on expectations of a recovery in traded volumes. MCX offers a listed comparable, though any read-across warrants a discount for NCDEX's smaller turnover base, regulatory constraints and the illiquidity inherent in unlisted securities.
Risk Factors
Regulatory concentration, with a single policy decision materially affecting revenue Sustained operating losses across recent financial years Execution risk in establishing an equity derivatives segment against established incumbents Absence of a filed offer document, leaving exit dependent on secondary market demand Limited liquidity and less frequent disclosure than listed securities
Investment View
NCDEX represents regulated market infrastructure operating below capacity due to a policy restriction. A relaxation would allow operating leverage to work in the company's favour; continuation places the burden on its diversification strategy. Suited to investors with a multi-year horizon who do not require a defined exit timeline.